Global Remicade (infliximab) Drug Sales Market Report 2018

レミケード(インフリキシマブ)薬の世界市場:販売動向2018

◆タイトル:Global Remicade (infliximab) Drug Sales Market Report 2018
◆商品コード:QYR80711080
◆調査・発行会社:QYResearch
◆発行日:2018年10月
◆ページ数:101
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、レミケード(インフリキシマブ)薬の世界市場について調査・分析し、レミケード(インフリキシマブ)薬のメーカー別販売量、市場シェア分析、種類別販売分析(ブランド薬、ジェネリック医薬品)、用途別販売分析(クローン病、小児クローン病、潰瘍性大腸炎、小児性潰瘍性大腸炎、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、レミケード(インフリキシマブ)薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・レミケード(インフリキシマブ)薬市場概要
・レミケード(インフリキシマブ)薬のメーカー別販売量・メーカー別シェア
・レミケード(インフリキシマブ)薬の世界市場:種類別販売量(ブランド薬、ジェネリック医薬品)
・レミケード(インフリキシマブ)薬の世界市場:用途別販売量(クローン病、小児クローン病、潰瘍性大腸炎、小児性潰瘍性大腸炎、その他)
・レミケード(インフリキシマブ)薬の世界市場:地域別販売量・市場シェア
・レミケード(インフリキシマブ)薬の米国市場規模
・レミケード(インフリキシマブ)薬の中国市場規模
・レミケード(インフリキシマブ)薬の欧州市場規模
・レミケード(インフリキシマブ)薬の日本市場規模
・レミケード(インフリキシマブ)薬の東南アジア市場規模
・レミケード(インフリキシマブ)薬のインド市場規模
・レミケード(インフリキシマブ)薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・レミケード(インフリキシマブ)薬のコスト分析・価格動向
・レミケード(インフリキシマブ)薬の産業チェーン(サプライチェーン分析)
・レミケード(インフリキシマブ)薬のマーケティング戦略・販売チャネル、流通業者
・レミケード(インフリキシマブ)薬市場への影響要因分析
・レミケード(インフリキシマブ)薬の世界市場予測
・レミケード(インフリキシマブ)薬の米国市場予測
・レミケード(インフリキシマブ)薬の中国市場予測
・レミケード(インフリキシマブ)薬の欧州市場予測
・レミケード(インフリキシマブ)薬の日本市場予測
・レミケード(インフリキシマブ)薬の東南アジア市場予測
・レミケード(インフリキシマブ)薬のインド市場予測
・レミケード(インフリキシマブ)薬の種類別世界市場予測(ブランド薬、ジェネリック医薬品)
・レミケード(インフリキシマブ)薬の用途別世界市場予測(クローン病、小児クローン病、潰瘍性大腸炎、小児性潰瘍性大腸炎、その他)
...

This report studies the global Remicade (infliximab) Drug market status and forecast, categorizes the global Remicade (infliximab) Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
The global Remicade (infliximab) Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Brands Drugs
Generic Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Crohn’s Disease
Pediatric Crohn’s Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other

The study objectives of this report are:
To analyze and study the global Remicade (infliximab) Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Remicade (infliximab) Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Remicade (infliximab) Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Remicade (infliximab) Drug Manufacturers
Remicade (infliximab) Drug Distributors/Traders/Wholesalers
Remicade (infliximab) Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Remicade (infliximab) Drug market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Remicade (infliximab) Drug Sales Market Report 2018
1 Remicade (infliximab) Drug Market Overview
1.1 Product Overview and Scope of Remicade (infliximab) Drug
1.2 Classification of Remicade (infliximab) Drug by Product Category
1.2.1 Global Remicade (infliximab) Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Remicade (infliximab) Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Brands Drugs
1.2.4 Generic Drugs
1.3 Global Remicade (infliximab) Drug Market by Application/End Users
1.3.1 Global Remicade (infliximab) Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Crohn’s Disease
1.3.2 Pediatric Crohn’s Disease
1.3.3 Ulcerative Colitis
1.3.4 Pediatric Ulcerative Colitis
1.3.5 Other
1.4 Global Remicade (infliximab) Drug Market by Region
1.4.1 Global Remicade (infliximab) Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Remicade (infliximab) Drug Status and Prospect (2013-2025)
1.4.3 Europe Remicade (infliximab) Drug Status and Prospect (2013-2025)
1.4.4 China Remicade (infliximab) Drug Status and Prospect (2013-2025)
1.4.5 Japan Remicade (infliximab) Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Remicade (infliximab) Drug Status and Prospect (2013-2025)
1.4.7 India Remicade (infliximab) Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Remicade (infliximab) Drug (2013-2025)
1.5.1 Global Remicade (infliximab) Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Remicade (infliximab) Drug Revenue and Growth Rate (2013-2025)

2 Global Remicade (infliximab) Drug Competition by Players/Suppliers, Type and Application
2.1 Global Remicade (infliximab) Drug Market Competition by Players/Suppliers
2.1.1 Global Remicade (infliximab) Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Remicade (infliximab) Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Remicade (infliximab) Drug (Volume and Value) by Type
2.2.1 Global Remicade (infliximab) Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Remicade (infliximab) Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Remicade (infliximab) Drug (Volume and Value) by Region
2.3.1 Global Remicade (infliximab) Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Remicade (infliximab) Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Remicade (infliximab) Drug (Volume) by Application

3 United States Remicade (infliximab) Drug (Volume, Value and Sales Price)
3.1 United States Remicade (infliximab) Drug Sales and Value (2013-2018)
3.1.1 United States Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Remicade (infliximab) Drug Sales Price Trend (2013-2018)
3.2 United States Remicade (infliximab) Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Remicade (infliximab) Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Remicade (infliximab) Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Remicade (infliximab) Drug (Volume, Value and Sales Price)
4.1 Europe Remicade (infliximab) Drug Sales and Value (2013-2018)
4.1.1 Europe Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Remicade (infliximab) Drug Sales Price Trend (2013-2018)
4.2 Europe Remicade (infliximab) Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Remicade (infliximab) Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Remicade (infliximab) Drug Sales Volume and Market Share by Application (2013-2018)

5 China Remicade (infliximab) Drug (Volume, Value and Sales Price)
5.1 China Remicade (infliximab) Drug Sales and Value (2013-2018)
5.1.1 China Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.1.2 China Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Remicade (infliximab) Drug Sales Price Trend (2013-2018)
5.2 China Remicade (infliximab) Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Remicade (infliximab) Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Remicade (infliximab) Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Remicade (infliximab) Drug (Volume, Value and Sales Price)
6.1 Japan Remicade (infliximab) Drug Sales and Value (2013-2018)
6.1.1 Japan Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Remicade (infliximab) Drug Sales Price Trend (2013-2018)
6.2 Japan Remicade (infliximab) Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Remicade (infliximab) Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Remicade (infliximab) Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Remicade (infliximab) Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Remicade (infliximab) Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Remicade (infliximab) Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Remicade (infliximab) Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Remicade (infliximab) Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Remicade (infliximab) Drug Sales Volume and Market Share by Application (2013-2018)

8 India Remicade (infliximab) Drug (Volume, Value and Sales Price)
8.1 India Remicade (infliximab) Drug Sales and Value (2013-2018)
8.1.1 India Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.1.2 India Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Remicade (infliximab) Drug Sales Price Trend (2013-2018)
8.2 India Remicade (infliximab) Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Remicade (infliximab) Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Remicade (infliximab) Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Remicade (infliximab) Drug Players/Suppliers Profiles and Sales Data
9.1 Janssen
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Remicade (infliximab) Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Janssen Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Hospira
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Remicade (infliximab) Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Hospira Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Celltrion Healthcare
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Remicade (infliximab) Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Epirus Biopharmaceuticals
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Remicade (infliximab) Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Samsung Bioepsis
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Remicade (infliximab) Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview

10 Remicade (infliximab) Drug Maufacturing Cost Analysis
10.1 Remicade (infliximab) Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Remicade (infliximab) Drug
10.3 Manufacturing Process Analysis of Remicade (infliximab) Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Remicade (infliximab) Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Remicade (infliximab) Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Remicade (infliximab) Drug Market Forecast (2018-2025)
14.1 Global Remicade (infliximab) Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Remicade (infliximab) Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Remicade (infliximab) Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Remicade (infliximab) Drug Price and Trend Forecast (2018-2025)
14.2 Global Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Remicade (infliximab) Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Remicade (infliximab) Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Remicade (infliximab) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Remicade (infliximab) Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Remicade (infliximab) Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Remicade (infliximab) Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Remicade (infliximab) Drug Price Forecast by Type (2018-2025)
14.4 Global Remicade (infliximab) Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Remicade (infliximab) Drug
Figure Global Remicade (infliximab) Drug Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Remicade (infliximab) Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Brands Drugs Product Picture
Figure Generic Drugs Product Picture
Figure Global Remicade (infliximab) Drug Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Remicade (infliximab) Drug by Application in 2017
Figure Crohn's Disease Examples
Table Key Downstream Customer in Crohn's Disease
Figure Pediatric Crohn's Disease Examples
Table Key Downstream Customer in Pediatric Crohn's Disease
Figure Ulcerative Colitis Examples
Table Key Downstream Customer in Ulcerative Colitis
Figure Pediatric Ulcerative Colitis Examples
Table Key Downstream Customer in Pediatric Ulcerative Colitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Remicade (infliximab) Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Remicade (infliximab) Drug Sales Volume (K Units) (2013-2018)
Table Global Remicade (infliximab) Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Remicade (infliximab) Drug Sales Share by Players/Suppliers
Figure 2017 Remicade (infliximab) Drug Sales Share by Players/Suppliers
Figure Global Remicade (infliximab) Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Remicade (infliximab) Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Remicade (infliximab) Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Remicade (infliximab) Drug Revenue Share by Players
Table 2017 Global Remicade (infliximab) Drug Revenue Share by Players
Table Global Remicade (infliximab) Drug Sales (K Units) and Market Share by Type (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Remicade (infliximab) Drug by Type (2013-2018)
Figure Global Remicade (infliximab) Drug Sales Growth Rate by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Remicade (infliximab) Drug by Type (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue Growth Rate by Type (2013-2018)
Table Global Remicade (infliximab) Drug Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Remicade (infliximab) Drug by Region (2013-2018)
Figure Global Remicade (infliximab) Drug Sales Growth Rate by Region in 2017
Table Global Remicade (infliximab) Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Remicade (infliximab) Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Remicade (infliximab) Drug by Region (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue Growth Rate by Region in 2017
Table Global Remicade (infliximab) Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Remicade (infliximab) Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Remicade (infliximab) Drug by Region (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue Market Share by Region in 2017
Table Global Remicade (infliximab) Drug Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Remicade (infliximab) Drug by Application (2013-2018)
Figure Global Remicade (infliximab) Drug Sales Market Share by Application (2013-2018)
Figure United States Remicade (infliximab) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure United States Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Remicade (infliximab) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table United States Remicade (infliximab) Drug Sales Volume (K Units) by Players (2013-2018)
Table United States Remicade (infliximab) Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Remicade (infliximab) Drug Sales Volume Market Share by Players in 2017
Table United States Remicade (infliximab) Drug Sales Volume (K Units) by Type (2013-2018)
Table United States Remicade (infliximab) Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Remicade (infliximab) Drug Sales Volume Market Share by Type in 2017
Table United States Remicade (infliximab) Drug Sales Volume (K Units) by Application (2013-2018)
Table United States Remicade (infliximab) Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Remicade (infliximab) Drug Sales Volume Market Share by Application in 2017
Figure Europe Remicade (infliximab) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Remicade (infliximab) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Volume (K Units) by Players (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Remicade (infliximab) Drug Sales Volume Market Share by Players in 2017
Table Europe Remicade (infliximab) Drug Sales Volume (K Units) by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Remicade (infliximab) Drug Sales Volume Market Share by Type in 2017
Table Europe Remicade (infliximab) Drug Sales Volume (K Units) by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Remicade (infliximab) Drug Sales Volume Market Share by Application in 2017
Figure China Remicade (infliximab) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure China Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Remicade (infliximab) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table China Remicade (infliximab) Drug Sales Volume (K Units) by Players (2013-2018)
Table China Remicade (infliximab) Drug Sales Volume Market Share by Players (2013-2018)
Figure China Remicade (infliximab) Drug Sales Volume Market Share by Players in 2017
Table China Remicade (infliximab) Drug Sales Volume (K Units) by Type (2013-2018)
Table China Remicade (infliximab) Drug Sales Volume Market Share by Type (2013-2018)
Figure China Remicade (infliximab) Drug Sales Volume Market Share by Type in 2017
Table China Remicade (infliximab) Drug Sales Volume (K Units) by Application (2013-2018)
Table China Remicade (infliximab) Drug Sales Volume Market Share by Application (2013-2018)
Figure China Remicade (infliximab) Drug Sales Volume Market Share by Application in 2017
Figure Japan Remicade (infliximab) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Remicade (infliximab) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Remicade (infliximab) Drug Sales Volume (K Units) by Players (2013-2018)
Table Japan Remicade (infliximab) Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Remicade (infliximab) Drug Sales Volume Market Share by Players in 2017
Table Japan Remicade (infliximab) Drug Sales Volume (K Units) by Type (2013-2018)
Table Japan Remicade (infliximab) Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Remicade (infliximab) Drug Sales Volume Market Share by Type in 2017
Table Japan Remicade (infliximab) Drug Sales Volume (K Units) by Application (2013-2018)
Table Japan Remicade (infliximab) Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Remicade (infliximab) Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Remicade (infliximab) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Remicade (infliximab) Drug Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Remicade (infliximab) Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Remicade (infliximab) Drug Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Remicade (infliximab) Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Remicade (infliximab) Drug Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Remicade (infliximab) Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Sales Volume Market Share by Application in 2017
Figure India Remicade (infliximab) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure India Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Remicade (infliximab) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table India Remicade (infliximab) Drug Sales Volume (K Units) by Players (2013-2018)
Table India Remicade (infliximab) Drug Sales Volume Market Share by Players (2013-2018)
Figure India Remicade (infliximab) Drug Sales Volume Market Share by Players in 2017
Table India Remicade (infliximab) Drug Sales Volume (K Units) by Type (2013-2018)
Table India Remicade (infliximab) Drug Sales Volume Market Share by Type (2013-2018)
Figure India Remicade (infliximab) Drug Sales Volume Market Share by Type in 2017
Table India Remicade (infliximab) Drug Sales Volume (K Units) by Application (2013-2018)
Table India Remicade (infliximab) Drug Sales Volume Market Share by Application (2013-2018)
Figure India Remicade (infliximab) Drug Sales Volume Market Share by Application in 2017
Table Janssen Basic Information List
Table Janssen Remicade (infliximab) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Remicade (infliximab) Drug Sales Growth Rate (2013-2018)
Figure Janssen Remicade (infliximab) Drug Sales Global Market Share (2013-2018)
Figure Janssen Remicade (infliximab) Drug Revenue Global Market Share (2013-2018)
Table Hospira Basic Information List
Table Hospira Remicade (infliximab) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hospira Remicade (infliximab) Drug Sales Growth Rate (2013-2018)
Figure Hospira Remicade (infliximab) Drug Sales Global Market Share (2013-2018)
Figure Hospira Remicade (infliximab) Drug Revenue Global Market Share (2013-2018)
Table Celltrion Healthcare Basic Information List
Table Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celltrion Healthcare Remicade (infliximab) Drug Sales Growth Rate (2013-2018)
Figure Celltrion Healthcare Remicade (infliximab) Drug Sales Global Market Share (2013-2018
Figure Celltrion Healthcare Remicade (infliximab) Drug Revenue Global Market Share (2013-2018)
Table Epirus Biopharmaceuticals Basic Information List
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales Growth Rate (2013-2018)
Figure Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales Global Market Share (2013-2018)
Figure Epirus Biopharmaceuticals Remicade (infliximab) Drug Revenue Global Market Share (2013-2018)
Table Samsung Bioepsis Basic Information List
Table Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Samsung Bioepsis Remicade (infliximab) Drug Sales Growth Rate (2013-2018)
Figure Samsung Bioepsis Remicade (infliximab) Drug Sales Global Market Share (2013-2018)
Figure Samsung Bioepsis Remicade (infliximab) Drug Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Remicade (infliximab) Drug
Figure Manufacturing Process Analysis of Remicade (infliximab) Drug
Figure Remicade (infliximab) Drug Industrial Chain Analysis
Table Raw Materials Sources of Remicade (infliximab) Drug Major Players in 2017
Table Major Buyers of Remicade (infliximab) Drug
Table Distributors/Traders List
Figure Global Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Remicade (infliximab) Drug Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Remicade (infliximab) Drug Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Remicade (infliximab) Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Remicade (infliximab) Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Remicade (infliximab) Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Remicade (infliximab) Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Remicade (infliximab) Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Remicade (infliximab) Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Remicade (infliximab) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Remicade (infliximab) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Remicade (infliximab) Drug Sales (K Units) Forecast by Type (2018-2025)
Figure Global Remicade (infliximab) Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Remicade (infliximab) Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Remicade (infliximab) Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Remicade (infliximab) Drug Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Remicade (infliximab) Drug Sales (K Units) Forecast by Application (2018-2025)
Figure Global Remicade (infliximab) Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

レミケード(インフリキシマブ)薬、ブランド薬、ジェネリック医薬品、クローン病、小児クローン病、潰瘍性大腸炎、小児性潰瘍性大腸炎

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[レミケード(インフリキシマブ)薬の世界市場:販売動向2018] (Global Remicade (infliximab) Drug Sales Market Report 2018 / QYR80711080)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆